Cleared Traditional

K211729 - Comprehensive Convertible Glenoid - Viv...

K211729 is the FDA 510(k) clearance for Comprehensive Convertible Glenoid - Viv... by Biomet Manufacturing Corp. It is a Class 2 Orthopedic device (product code PHX) cleared through the Traditional 510(k) pathway after a 153-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2021
Decision
153d
Days
Class 2
Risk

K211729 is an FDA 510(k) clearance for the Comprehensive® Convertible Glenoid - Vivacit-E Liner. Classified as Shoulder Prosthesis, Reverse Configuration (product code PHX), Class II - Special Controls.

Submitted by Biomet Manufacturing Corp (Warsaw, US). The FDA issued a Cleared decision on November 4, 2021 after a review of 153 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3660 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Biomet Manufacturing Corp devices

Submission Details

510(k) Number K211729 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2021
Decision Date November 04, 2021
Days to Decision 153 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d slower than avg
Panel avg: 122d · This submission: 153d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PHX Shoulder Prosthesis, Reverse Configuration
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3660
Definition Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - PHX Shoulder Prosthesis, Reverse Configuration

All 178
Devices cleared under the same product code (PHX) and FDA review panel - the closest regulatory comparables to K211729.
LINK® Embrace Shoulder System - Reverse Configuration
K212992 · Waldemar Link GmbH & Co. KG · Nov 2021
Arthrex Modular Glenoid System-Titanium Glenosphere
K212415 · Arthrex, Inc. · Nov 2021
Tornier Perform™ Patient-Matched Primary Reversed Glenoid and BLUEPRINT™ Patient Specific Instrumentation
K211359 · Tornier, Inc. · Nov 2021
Tomier Perform™ Reversed Glenoid Cannulated Glenospheres
K213124 · Tornier, Inc. · Oct 2021
GLOBAL UNITE™ Platform Shoulder System
K212710 · Depuy Ireland UC · Sep 2021
Univers Revers Modular Glenoid System, Standard Augment Baseplates
K211074 · Arthrex, Inc. · Sep 2021